From: Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma
Factors | SE | P | Exp (β) | 95% CI | ||
---|---|---|---|---|---|---|
T stage | T1/T2 | Â | Â | Reference | Â | Â |
T3/T4 | 0.487 | 0.529 | 1.359 | 0.523 | 3.530 | |
N stage | N0 | Â | Â | Reference | Â | Â |
N1-N3 | 0.602 | 0.008* | 4.969 | 1.527 | 16.168 | |
Clinical stage | I and II | Â | Â | Reference | Â | Â |
III and IV | 0.667 | 0.282 | 0.488 | 0.132 | 1.804 | |
CD8 | Low | 0.358 | 0.030* | 2.174 | 1.078 | 4.384 |
High | Â | Â | Reference | Â | Â | |
CD4 | Low | 0.328 | 0.909 | 1.038 | 0.545 | 1.977 |
High | Â | Â | Reference | Â | Â | |
T-bet | Low | 0.310 | 0.836 | 1.066 | 0.580 | 1.959 |
High | Â | Â | Reference | Â | Â | |
CD68 | Low | 0.316 | 0.177 | 1.533 | 0.825 | 2.848 |
High | Â | Â | Reference | Â | Â | |
CD57 | Low | 0.441 | <0.001* | 6.576 | 2.768 | 15.623 |
High | Â | Â | Reference | Â | Â |